Stocks in Focus on May 28: Eicher Motors, Metropolis Health, NOCIL, Hester Biosciences to JSW Steel; here are the 5 Newsmakers of the Day

Equity indices ended a volatile session with small gains on Thursday, May 27, 2021. The S&P BSE Sensex rose 97.70 points or 0.19% at 51,115.22. The Nifty 50 index gained 36.40 points or 0.24% at 15,337.85. But certain stocks came in the news after the market was closed. These stocks can impact the indices, when it reopens on Friday, May 28, 2021. List of such five stocks:

Eicher Motors + Sun Pharma

Eicher Motors: The Indian manufacturer of motorcycles and commercial vehicles on Thursday, May 27, 2021, reported a consolidated 73% YoY rise in profit at Rs 526 crore for the quarter ended March 31, 2021. The company has posted a profit of Rs 304 crore in the corresponding quarter of the last financial year. The consolidated revenue from operations rose 33.2% to Rs 2940 crore in the period under consideration as compared to Rs 2,208 crore posted last year. EBITDA grew 46.8% YoY to Rs 634 crore as compared to Rs 432 crore posted last year. The EBITDA margin improved to 21.6%in Q4FY21 as compared to 19.6%. Besides, the Board has approved a dividend of Rs 17 per equity share for the financial year ended March 31, 2021. Revenue from operations at an all-time high and VECV gained market share across segments. The second wave of the pandemic is impacting the automotive supply chain.

See Zee Business Live TV Streaming Below:

Sun Pharma: The pharmaceutical company has reported 2.2 times YoY rise in the profit at Rs 894 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 400 crore in the corresponding quarter of the last financial year. Revenue from operations grew 4.1% to Rs 8,523 crore as compared to Rs 8,185 crore posted last year. EBITDA grew 50% YoY to Rs 2,048 crore as compared to Rs 1,363 crore posted last year. Margin improved to 24.3% in Q4FY21 from 16.7% posted in Q4FY20. Profit before tax & Exceptions stood at Rs 1,575 crore as compared to Rs 838 crore posted last year. The board has recommended payment of a final dividend of Rs 2 per share.

US: Down 1.3%  

India: Up 13% 

Emerging Market: up 2.8% 

Rest of the World: Up 5.5% 

API Sales: Down 10% 

Exceptional Expense of 672 Cr Vs 270 Cr last year 

Lower Forex gains 

Metropolis + HEG + Goodyear + Dixon Tech

Metropolis Health: The operator of a chain of diagnostic companies Metropolis Health has reported a 296.8% YoY rise in the consolidated profit of Rs 61.5 crore for the quarter ended March 31, 2021. It had reported a profit of Rs 15.5 crore in the corresponding quarter last year. The revenue from operations grew 41.1% YoY to Rs 292 crore compared to Rs 207 crore posted last year. EBITDA grew 88.3% to Rs 97 crore as compared to Rs 51.5 crore posted last year. The EBITDA margin improved to 33.2% in Q4FY21 as compared to 24.9% posted in Q4FY20.

HEG: The carbon and graphite product manufacturing company has reported a consolidated loss YoY of Rs 16 crore for the quarter ended March 31, 2021, as compared to a loss of Rs 377 crore posted in the corresponding quarter last year. Consolidated revenue grew 1.6% to Rs 380 crore as compared to Rs 374 crore posted last year. EBITDA loss stood at Rs 5 crore as compared to a loss of Rs 497 crore. The board has approved a dividend of Rs 3/share.

Goodyear: The tire manufacturing company has reported a 230.8% YoY rise in profit at Rs 43 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 13 crore in the corresponding quarter last year. The sales rose 51.1% YoY to Rs 569 crore as compared to Rs 375 crore posted last year. The EBIDTA grew 191.7% to Rs 66.8 crore as compared to Rs 22.9 crore. The margin improved to 11.7% in Q4FY21 as compared to 6% posted in Q4FY20. The board has approved a final dividend of Rs 18 per equity share and a special dividend of Rs 80 per equity share.

Dixon Technologies: The company has reported a 57% YoY rise in the consolidated profit at Rs 44 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 28 crore in the corresponding quarter last year. Sales grew 146% YoY to Rs 2,110 crore as compared to Rs 857 crore posted last year. EBITDA grew 42.9% to Rs 80 crore as compared to Rs 56 crore. The margin dropped 3.8% in Q4FY21 as compared to 6.5% posted in Q4FY20. The board has approved a final dividend of Re 1/equity share.

NOCIL + Jindal Saw + GSFC + Waterbase

NOCIL: The chemical manufacturing company has reported a 70.3% YoY rise in the consolidated profit at Rs 37.3 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 21.9 crore in the corresponding quarter last year. Revenue grew 51.2% to Rs 322 crore as compared to Rs 213 crore posted last year. EBITDA grew 41.4% to Rs 52.3 crore as compared to Rs 37 crore posted last year. EBITDA margin dropped to 16.2% in Q4FY21 as compared to 17.4% posted in Q4FY20. The board has approved a final dividend of Rs 2/share.

Jindal Saw: The manufacturer of SAW Pipes and spiral pipes has reported a 457.6% YoY rise in the consolidated profit at Rs 184 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 33 crore in the same quarter last year. Consolidated revenue from operations grew 30.4% YoY to Rs 3,784 crore as compared to Rs 2,901 crore posted last year. EBITDA grew 20.6% to Rs 475 crore as compared to Rs 394 crore posted last year. The EBITDA margin declined to 12.6% in Q4FY21 as compared to 13.6% posted in Q4FY20. It has reported an exceptional loss of Rs 49 crore last year. The board has approved a dividend of Rs 2/share. Besides, the board also gave the approval to repurchase/buyback, Privately Placed Rated Secured Listed Redeemable NCDs. It also constituted a Restructuring Committee to explore/evaluate options of consolidation/ restructuring the various subsidiaries/affiliates/ associates of the Company.

GSFC:  The chemical industry company has reported a 141.9% rise in the consolidated profit at Rs 150 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 62 crore in the corresponding quarter last year. Sales dropped 6.6% to Rs 1,740 crore as compared to Rs 1,863 crore posted last year. EBITDA fell 1.4% YoY to Rs 144 crore as compared to Rs 146 crore posted last year. The margin improved to 8.3% in Q4FY21 as compared to 7.8% posted in Q4FY20. The board has approved a dividend of Rs 2.20 per equity shares.

Waterbase: The manufacturer of high-quality shrimp feed in India has reported a YoY loss of Rs 2.6 crore for the quarter ended March 31, 2021. It had posted a loss of Rs 2.5 crore in the corresponding quarter last year. The consolidated revenue fell 5.3% to Rs 45 crore as compared to Rs 47.5 crore posted last year. EBITDA loss stood at Rs 2.1 crore compared to a loss of Rs 1.6 crore posted last year. The board has approved a final dividend of Rs 1/share  

Hester Bio + Apollo Hospital/DRL 

Hester Biosciences: Hester Biosciences has said a memorandum of understanding (MoU) has been signed between vaccine maker Bharat Biotech and Gujarat Covid Vaccine Consortium (GCVC) for contract manufacturing the drug substance for COVAXIN. Hester shall provide the complete infrastructure at its Gujarat plant for the manufacturing of the Drug Substance. Bharat Biotech shall provide the technology for the production of the Drug Substance for COVAXIN. Hester has estimated an outlay of Rs 40 crore for this project.
Apollo Hospital / Dr Reddy: Apollo Hospitals will roll out administering Russian COVID-19 vaccine Sputnik V from the second week of June.

JSW Steel: Karnataka government has put a hold on the decision to sell 3,667 acres of land to JSW Steel in the Ballari district. The decision was taken at the case is pending in the court. The decision to sell the land parcel to JSW Steel was taken at the Cabinet meeting held on April 26.